Retrospective Clinical Analysis of Epilepsy Treatment for Children with Drug-Resistant Epilepsy (A Single-Center Experience)

被引:4
|
作者
Liu, Changqing [1 ,2 ,3 ]
Hu, Yue [1 ,4 ]
Zhou, Jian [1 ,2 ,3 ]
Guan, Yuguang [1 ,2 ,3 ]
Wang, Mengyang [3 ,5 ]
Qi, Xueling [6 ]
Wang, Xiongfei [1 ,3 ]
Zhang, Huawei [1 ]
Adilijiang, Aihemaitiniyazi [1 ]
Li, Tiemin [1 ]
Luan, Guoming [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China
[2] Capital Med Univ, Sanbo Brain Hosp, Beijing Key Lab Epilepsy, Beijing 100093, Peoples R China
[3] Capital Med Univ, Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing 100093, Peoples R China
[4] China Med Univ, Aviat Gen Hosp, Dept Neurosurg, Beijing 100012, Peoples R China
[5] Capital Med Univ, Sanbo Brain Hosp, Dept Neurol, Beijing 100093, Peoples R China
[6] Capital Med Univ, Sanbo Brain Hosp, Dept Pathol, Beijing 100093, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
drug-resistant epilepsy; children; resection surgery; palliative surgery; seizure outcome; FOCAL CORTICAL DYSPLASIA; LENNOX-GASTAUT-SYNDROME; LONG-TERM OUTCOMES; CATASTROPHIC EPILEPSY; ILAE COMMISSION; SURGERY; SEIZURE; HEMISPHERECTOMY; CLASSIFICATION; INTERVENTION;
D O I
10.3390/brainsci13010014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objectives: This retrospective cohort study investigated the clinical characteristics and seizure outcomes of patients aged 1-14 years with drug-resistant epilepsy (DRE) who were treated by different typologies of therapy. Methods: Four hundred and eighteen children with DRE were recruited from Sanbo Brain Hospital of Capital Medical University from April 2008 to February 2015. The patients were divided into three groups: medication (n = 134, 32.06%), resection surgery (n = 185, 44.26%), and palliative surgery (n = 99, 23.68%) groups. Demographic characteristics were attained from medical records. All patients were followed up for at least 5 years, with seizure outcomes classified according to International League Against Epilepsy criteria. The psychological outcome was evaluated with the development quotient and Wechsler Intelligence Quotient Scale for children (Chinese version). Results: The most frequent seizure type was generalized tonic seizure in 53.83% of patients. Age at seizure onset in 54.55% of patients was <3 years. The most frequent etiologies were focal cortical dysplasia (FCD). West syndrome was the most common epilepsy syndrome. Favorable seizure outcomes at the 5-year follow-up in the medication, resection surgery, and palliative surgery groups were 5.22%, 77.30%, and 14.14%, respectively. The patients showed varying degrees of improvement in terms of developmental and intellectual outcomes post-treatment. Conclusions: Pediatric patients with DRE were characterized by frequent seizures, a variety of seizure types, and complex etiology. Recurrent seizures severely affected the cognitive function and development of children. Early surgical intervention would be beneficial for seizure control and prevention of mental retardation. Palliative surgery was also a reasonable option for patients who were not suitable candidates for resection surgery.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] A Single-Center Evaluation of Responsive Neurostimulation as Treatment for Drug-resistant Epilepsy
    Beattie, Sean
    Guerrero, Gloria Ortiz
    Uysal, Utku
    NEUROLOGY, 2023, 100 (17)
  • [2] Evaluation of ketogenic diet therapy in children diagnosed with drug-resistant epilepsy: a single-center experience
    Yildirim, Gonca Kilic
    Yagci, Murat
    Uygur, Anul Cigdem
    Ozen, Hulya
    Yarar, Coskun
    Carman, Kursat Bora
    TURKISH JOURNAL OF PEDIATRICS, 2022, 64 (03) : 435 - 445
  • [3] Centromedian thalamic deep brain stimulation for drug-resistant epilepsy: single-center experience
    Yang, Jimmy C.
    Bullinger, Katie L.
    Isbaine, Faical
    Alwaki, Abdulrahman
    Opri, Enrico
    Willie, Jon T.
    Gross, Robert E.
    JOURNAL OF NEUROSURGERY, 2022, 137 (06) : 1591 - 1600
  • [4] Thalamic Stimulation for Drug-Resistant Epilepsy: A 7-Year, Single-Center Experience
    Hartl, E.
    Mehrkens, J. H.
    Boetzel, K.
    Feddersen, B.
    Remi, J.
    Vollmar, C.
    Noachtar, S.
    EPILEPSIA, 2018, 59 : S123 - S124
  • [5] PERAMPANEL AS ADD-ON TREATMENT IN PATIENTS WITH DRUG-RESISTANT FOCAL EPILEPSY: THE CLINICAL EXPERIENCE OF THE DANISH EPILEPSY CENTER
    Juhl, S.
    Rubboli, G.
    EPILEPSIA, 2014, 55 : 115 - 115
  • [6] Long Term Outcome Of Epilepsy Surgery For Drug-Resistant Epilepsy In Thailand, A Single Center Experience
    Asavaveeradech, K.
    Unnwongse, K.
    EPILEPSIA, 2019, 60 : 164 - 164
  • [7] Clinical predictors of drug-resistant epilepsy in children
    Karaoglu, Pakize
    Yis, Uluc
    Polat, Ayse Ipek
    Ayanoglu, Muge
    Hiz, Semra
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (03) : 1249 - 1252
  • [8] Cost Analysis of Epilepsy Surgery in Children with Drug-resistant Epilepsy
    Oldham, M. S.
    Tsevat, J.
    Horn, P.
    Standridge, S.
    ANNALS OF NEUROLOGY, 2014, 76 : S199 - S199
  • [9] Topiramate in drug-resistant epilepsy in children: Retrospective data
    Vittorini, R
    Pieri, I
    Canavese, C
    Capizzi, G
    EPILEPSIA, 2005, 46 : 238 - 238
  • [10] Costs and Clinical Outcomes of Epilepsy Surgery in Children With Drug-Resistant Epilepsy
    Oldham, Michael S.
    Horn, Paul S.
    Tsevat, Joel
    Standridge, Shannon
    PEDIATRIC NEUROLOGY, 2015, 53 (03) : 216 - 220